A moderate weight reduction through dietary intervention decreases hepatic fat content in patients with non-alcoholic fatty liver disease (NAFLD): a pilot study (Q47312991)

From Wikidata

Jump to navigation Jump to search

scientific article published on 28 April 2012

Language	Label	Description	Also known as
English	A moderate weight reduction through dietary intervention decreases hepatic fat content in patients with non-alcoholic fatty liver disease (NAFLD): a pilot study	scientific article published on 28 April 2012

Statements

scholarly article

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/22543623

A moderate weight reduction through dietary intervention decreases hepatic fat content in patients with non-alcoholic fatty liver disease (NAFLD): a pilot study (English)

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/22543623

metabolic dysfunction–associated steatotic liver disease

1 reference

based on heuristic

inferred from title

non-alcoholic fatty liver

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Jürgen Machann

2

object named as

Jürgen Machann

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/22543623

author name string

Valentina Volynets

1

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/22543623

Markus A Küper

3

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/22543623

Ina B Maier

4

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/22543623

Astrid Spruss

5

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/22543623

Alfred Königsrainer

6

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/22543623

Stephan C Bischoff

7

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/22543623

Ina Bergheim

8

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/22543623

publication date

28 April 2012

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/22543623

European Journal of Nutrition

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/22543623

52

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/22543623

2

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/22543623

527-535

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/22543623

https://scigraph.springernature.com/pub.10.1007/s00394-012-0355-z

0 references

The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0355-Z

21 January 2018

Increased orocecal transit time in patients with nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0355-Z

21 January 2018

Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease.

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0355-Z

21 January 2018

Susceptibility to gut leakiness: a possible mechanism for endotoxaemia in non-alcoholic steatohepatitis.

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0355-Z

21 January 2018

Obesity and female gender increase breath ethanol concentration: potential implications for the pathogenesis of nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0355-Z

21 January 2018

Fructose consumption as a risk factor for non-alcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0355-Z

21 January 2018

Soft drink consumption linked with fatty liver in the absence of traditional risk factors

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0355-Z

21 January 2018

Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0355-Z

21 January 2018

Fructose-induced fatty liver disease: hepatic effects of blood pressure and plasma triglyceride reduction

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0355-Z

21 January 2018

Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0355-Z

21 January 2018

Serotonin reuptake transporter (SERT) plays a critical role in the onset of fructose-induced hepatic steatosis in mice

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0355-Z

21 January 2018

Fructose-induced steatosis in mice: role of plasminogen activator inhibitor-1, microsomal triglyceride transfer protein and NKT cells.

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0355-Z

21 January 2018

Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice.

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0355-Z

21 January 2018

Protective effect of bile acids on the onset of fructose-induced hepatic steatosis in mice

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0355-Z

21 January 2018

Cellobiose and lactulose coupled with mannitol and determined using ion-exchange chromatography with pulsed amperometric detection, are reliable probes for investigation of intestinal permeability

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0355-Z

21 January 2018

Intestinal permeability in patients with chronic liver diseases: Its relationship with the aetiology and the entity of liver damage.

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0355-Z

21 January 2018

Prevalence of small bowel bacterial overgrowth and its association with nutrition intake in nonhospitalized older adults

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0355-Z

21 January 2018

Assessment of the reproducibility of the lactulose H2 breath test as a measure of mouth to caecum transit time

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0355-Z

21 January 2018

Nonalcoholic fatty liver disease and low-carbohydrate diets

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0355-Z

21 January 2018

The effect of lifestyle changes in non-alcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0355-Z

21 January 2018

Kupffer cells in non-alcoholic fatty liver disease: the emerging view.

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0355-Z

21 January 2018

One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0355-Z

21 January 2018

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0355-Z

21 January 2018

Weight-loss with low or high carbohydrate diet?

1 reference

https://pubmed.ncbi.nlm.nih.gov/22543623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: a systematic review.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22543623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatic lipid accumulation in healthy subjects: A comparative study using spectral fat-selective MRI and volume-localized1H-MR spectroscopy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22543623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake

1 reference

https://pubmed.ncbi.nlm.nih.gov/22543623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Standardized assessment of whole body adipose tissue topography by MRI

1 reference

https://pubmed.ncbi.nlm.nih.gov/22543623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An enzymatic method for the microdetermination of ethanol

1 reference

https://pubmed.ncbi.nlm.nih.gov/22543623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Parallel determination of gut permeability in man with M(r) 400, M(r) 1500, M(r) 4000 and M(r) 10,000 polyethylene glycol

1 reference

https://pubmed.ncbi.nlm.nih.gov/22543623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Validation and comparison of two computerized methods of obtaining a diet history

1 reference

https://pubmed.ncbi.nlm.nih.gov/22543623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00394-012-0355-Z

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/22543623

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/22543623

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47312991&oldid=2151808821"